Corteva Inc. (CTVA)
NYSE: CTVA
· Real-Time Price · USD
71.23
0.28 (0.39%)
At close: Jun 03, 2025, 3:59 PM
71.30
0.09%
After-hours: Jun 03, 2025, 07:39 PM EDT
Corteva Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|
Crop Protection Revenue | 3.6B | 6.45B | 5.96B | 5.62B | 5.18B | 5.11B |
Crop Protection Revenue Growth | -44.18% | +8.26% | +6.00% | +8.41% | +1.39% | n/a |
Seed Revenue | 6.5B | 4.03B | 4.59B | 3.81B | 3.28B | 3.27B |
Seed Revenue Growth | +61.03% | -12.13% | +20.34% | +16.31% | +0.31% | n/a |
Revenue by Geography
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|
Asia Pacific Revenue | 1.35B | 1.36B | 1.46B | 1.45B | 1.4B | 1.29B |
Asia Pacific Revenue Growth | -1.10% | -6.64% | +0.62% | +3.50% | +8.85% | n/a |
Brazil Revenue | 2.62B | 2.52B | 3.14B | 2.31B | 1.72B | 1.79B |
Brazil Revenue Growth | +3.77% | -19.57% | +35.51% | +34.28% | -3.90% | n/a |
Canada Revenue | 794M | 807M | 741M | 754M | 658M | 674M |
Canada Revenue Growth | -1.61% | +8.91% | -1.72% | +14.59% | -2.37% | n/a |
Emea Revenue | 3.12B | 3.37B | 3.26B | 3.12B | 2.84B | 2.74B |
Emea Revenue Growth | -7.22% | +3.41% | +4.26% | +9.89% | +3.72% | n/a |
Latin America Revenue | 3.78B | 3.91B | 4.45B | 3.54B | 2.81B | 2.89B |
Latin America Revenue Growth | -3.33% | -12.13% | +25.39% | +26.38% | -2.91% | n/a |
United States Revenue | 7.87B | 7.78B | 7.55B | 6.78B | 6.51B | 6.25B |
United States Revenue Growth | +1.07% | +3.05% | +11.37% | +4.18% | +4.08% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 751M | 626M | 708M | 1.09B | 736M | 735M | 670M | 1.04B | 726M | 764M | 657M | 1.02B | 735M | 806M | 672M | 998M | 733M | 724M | 597M | 965M | 757M | 747M | 646M | 937M | 970M | 555M | 633M | 965M | 959M | 643M | 668M | 830.5M | 830.5M |
Selling, General, and Administrative Revenue Growth | +19.97% | -11.58% | -35.05% | +48.10% | +0.14% | +9.70% | -35.89% | +43.94% | -4.97% | +16.29% | -35.40% | +38.37% | -8.81% | +19.94% | -32.67% | +36.15% | +1.24% | +21.27% | -38.13% | +27.48% | +1.34% | +15.63% | -31.06% | -3.40% | +74.77% | -12.32% | -34.40% | +0.63% | +49.14% | -3.74% | -19.57% | 0.00% | n/a |
Research and Development Revenue | 335M | 365M | 348M | 357M | 332M | 357M | 335M | 329M | 316M | 340M | 312M | 296M | 268M | 316M | 297M | 293M | 281M | 305M | 284M | 273M | 280M | 290M | 289M | 269M | 355M | 379M | 325M | 354M | 382M | 383M | 387M | 369.5M | 369.5M |
Research and Development Revenue Growth | -8.22% | +4.89% | -2.52% | +7.53% | -7.00% | +6.57% | +1.82% | +4.11% | -7.06% | +8.97% | +5.41% | +10.45% | -15.19% | +6.40% | +1.37% | +4.27% | -7.87% | +7.39% | +4.03% | -2.50% | -3.45% | +0.35% | +7.43% | -24.23% | -6.33% | +16.62% | -8.19% | -7.33% | -0.26% | -1.03% | +4.74% | 0.00% | n/a |